Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission | Zendy

Hyuk Yoon | Zendy; Sushrut Jangi | Zendy; Parambir S. Dulai | Zendy; Brigid S. Boland | Zendy; Vipul Jairath | Zendy; Brian G. Feagan | Zendy; William J. Sandborn | Zendy; Siddharth Singh | Zendy

Open Access

Histologic Remission Is Associated With Lower Risk of Treatment Failure in Patients With Crohn Disease in Endoscopic Remission

Author(s) -

Hyuk Yoon,

Sushrut Jangi,

Parambir S. Dulai,

Brigid S. Boland,

Vipul Jairath,

Brian G. Feagan,

William J. Sandborn,

Siddharth Singh

Publication year - 2020

Publication title -

inflammatory bowel diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.932

H-Index - 146

eISSN - 1536-4844

pISSN - 1078-0998

DOI - 10.1093/ibd/izaa301

Subject(s) - medicine , hazard ratio , crohn's disease , gastroenterology , confidence interval , complete remission , surgery , retrospective cohort study , disease , chemotherapy

Although achieving histologic remission in ulcerative colitis is established, the incremental benefit of achieving histologic remission in patients with Crohn disease (CD) treated to a target of endoscopic remission is unclear. We evaluated the risk of treatment failure in patients with CD in clinical and endoscopic remission by histologic activity status.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research